3 results
Approved WMOCompleted
Primary Safety Objective * Proportion of patients who complete 24 weeks of combination treatment on pirfenidone at a dose of 1602*2403 mg/d and nintedanib at a dose of 200*300 mg/d Secondary Safety Objective * Proportion of patients who discontinue…
Approved WMOPending
The main purpose of the studies suggested in this proposal is to scientifically test the digital workflow in implant dentistry. The following primary and secundary goals are pursued:Primairy: 1. Assessment of the clinical use of intra-oral scanning…
Approved WMOWill not start
To determine the efficacy of subcutaneous administration of brodalumab compared with placebo in treating adolescents with moderate-to-severe plaque psoriasis.